Indian pharma companies, which are already playing a role in the consolidation process, will increase their share of the generics market not only in the U.S. but also in other markets, he added. A consolidation among pharmacies and intensifying competition have sent prices for generic drugs in the U.S., ...
Read more: Davos WEF 2018: Downturn In Generics Won't Last Long, Says Sun Pharma Chairman